LAUSANNE, Switzerland, July 14, 2011 /PRNewswire/ --
Debiopharm Group™ (Debiopharm), a Swiss-based global
biopharmaceutical group of companies with a focus on the
development of innovative therapies, primarily in oncology, has
appointed a number of management figures to key positions,